{"slideshow_credits": null, "snippet": "In presenting long-term financial estimates, AstraZeneca said it expected to achieve annual revenue of $45 billion by 2023, suggesting Pfizer\u2019s bid undervalued the company.", "abstract": "In presenting long-term financial estimates, AstraZeneca said it expected to achieve annual revenue of $45 billion by 2023, suggesting Pfizer\u2019s bid undervalued the company.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Jenny", "role": "reported", "lastname": "ANDERSON", "rank": 1, "organization": ""}, {"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 2, "organization": ""}, {"firstname": "Stephen", "role": "reported", "lastname": "CASTLE", "rank": 3, "organization": ""}], "original": "By JENNY ANDERSON, DAVID GELLES and STEPHEN CASTLE"}, "web_url": "http://dealbook.nytimes.com/2014/05/06/astrazeneca-makes-case-against-pfizers-bid/", "lead_paragraph": null, "headline": {"main": "AstraZeneca Makes Its Case Against Pfizer's Takeover Bid", "print_headline": "AstraZeneca Makes Its Case Against Pfizer&#8217;s Takeover Bid", "kicker": "DealBook"}, "_id": "5368cfa138f0d8698e5e08d1", "word_count": "1211", "multimedia": [{"height": 126, "url": "images/2014/05/07/business/dbpix-astrazeneca1/dbpix-astrazeneca1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/07/business/dbpix-astrazeneca1/dbpix-astrazeneca1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 440, "url": "images/2014/05/07/business/dbpix-astrazeneca1/dbpix-astrazeneca1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/07/business/dbpix-astrazeneca1/dbpix-astrazeneca1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "440"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/07/business/dbpix-astrazeneca1/dbpix-astrazeneca1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/07/business/dbpix-astrazeneca1/dbpix-astrazeneca1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-06T08:02:52Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Johansson, Leif", "rank": "1"}, {"name": "glocations", "value": "Great Britain", "rank": "1"}, {"name": "organizations", "value": "Pfizer Inc", "rank": "2"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}